↓ Skip to main content

Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial

Overview of attention for article published in Trials, January 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

blogs
1 blog
twitter
2 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
124 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial
Published in
Trials, January 2013
DOI 10.1186/1745-6215-14-112
Pubmed ID
Authors

Berit Rosche, Klaus-Dieter Wernecke, Stephanie Ohlraun, Jan-Markus D�rr, Friedemann Paul

Abstract

Trichuris suis ova is a probiotic treatment based on the hygiene hypothesis. It has been demonstrated as safe and effective in autoimmune inflammatory bowel diseases and clinical trials indicate that helminth infections also have an immunomodulatory effect in multiple sclerosis.We hypothesize that administering 2,500 Trichuris suis ova eggs orally every two weeks for 12 months is--due to its immunomodulatory and anti-inflammatory effect--significantly more effective than oral placebo in preventing new T2 and Gd+ lesions, as quantified by cerebral MRI and clinical examination, in relapsing-remitting multiple sclerosis and clinically isolated syndrome.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Czechia 1 <1%
Germany 1 <1%
South Africa 1 <1%
Unknown 121 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 19 15%
Researcher 17 14%
Student > Master 16 13%
Student > Ph. D. Student 15 12%
Other 13 10%
Other 27 22%
Unknown 17 14%
Readers by discipline Count As %
Medicine and Dentistry 49 40%
Biochemistry, Genetics and Molecular Biology 16 13%
Agricultural and Biological Sciences 10 8%
Immunology and Microbiology 7 6%
Neuroscience 7 6%
Other 16 13%
Unknown 19 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2015.
All research outputs
#896,679
of 8,149,094 outputs
Outputs from Trials
#373
of 2,242 outputs
Outputs of similar age
#15,120
of 124,839 outputs
Outputs of similar age from Trials
#13
of 69 outputs
Altmetric has tracked 8,149,094 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,242 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 124,839 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.